Most people don't have the time to thoroughly research cannabis stocks, nor the experience to know when to buy or sell - this is where CST comes in.
We give everyday traders the opportunity to look over the shoulder of an equities analyst with a passion for the cannabis sector.
Members of CST get daily analysis and access to a model portfolio so they can review cannabis investments like a pro.
Leading The Way
Michael Vodicka is a globally syndicated equity analyst with more than 20 years of experience in trading and investing. His research has been featured in some of the industry’s most respected publications.
He has been investing and leading investors in the cannabis sector since 2013. Now, Mr. Vodicka brings his expertise and guidance to the members of Cannabis Stock Trades.
The U.S. cannabis industry has a powerful new ally – one of the largest and most influential tech companies ever. Not only does this tech goliath support federal cannabis legalization, but it will also invest millions lobbying Congress to make it happen.
Cannabis investors looking to buy low need to check out the biggest cannabis stock IPO of 2021.
An early industry leader valued at $1.7 billion just began trading on the Canadian Stock Exchange. And while this company is delivering crazy sales growth, shares have hardly moved since going public, making this a bargain opportunity in the cannabis sector. Continue “$1.7 Billion Cannabis Stock IPO: Buy or Pass?”
For the last few years, the cannabis sector has experienced extended periods of strength followed by large pullbacks that lasted on average three to six months. During this period, buying cannabis stocks on a pullback has been a highly effective strategy.
Today, investors want to know if this a good time to buy cannabis stocks…